Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro. - Bart S. Hendriks; Kelly M. Seidl; Jeffrey R. Chabot (BMC Syst. Biol., 2010)

Comprehensive mechanism-based antibody pharmacokinetic modeling. - Jeffrey R. Chabot; Danielle E. Dettling; Paul J. Jasper; Bruce C. Gomes (EMBC, 2011)

A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs. - Georgi I. Kapitanov; Jeffrey R. Chabot; Jatin Narula; Mahua Roy; Hendrik Neubert; Joe Palandra; Vahid Farrokhi; Jay S. Johnson; Robert Webster; Hannah M. Jones (Frontiers Bioinform., 2021)